Wednesday, May 03, 2017 12:59:09 PM
"DECN now has a chance to succeed simply because the market for glucose monitoring strips is so large. Even a 1% worldwide market share would yield nearly a hundred million in annual gross revenue (50 test strips cost about $16 to $18). And the annual market for glucose test strips is growing thanks to the U.S. obesity epidemic. The point of care diagnostic industry is expected to grow to nearly $40 billion by 2021. Diabetes management via glucose monitoring diagnostics industry market has reached nearly $10 billion per year. DECN strips are compatible with the industry standard diagnostic equipment, even monitors made by Johnson & Johnson. One would expect any equivalent product at a lower price to gain market share, and DECN claims to have a superior product as well as being less expensive. The company stated on December 1, 2016, that it has ramped up its marketing, manufacturing, and distribution efforts after having gained legal grounds to execute its business plan. One should monitor company sales before investing in this high risk situation."
Full Article: https://seekingalpha.com/article/4060752-4-companies-stand-benefit-lower-healthcare-prices
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM